Abera Bioscience AB (XSAT:ABERA) Additional Paid-In Capital : kr68.76 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Abera Bioscience AB Additional Paid-In Capital?

Abera Bioscience AB's quarterly additional paid-in capital declined from Sep. 2023 (kr64.99 Mil) to Dec. 2023 (kr64.86 Mil) but then increased from Dec. 2023 (kr64.86 Mil) to Mar. 2024 (kr68.76 Mil).

Abera Bioscience AB's annual additional paid-in capital increased from Dec. 2021 (kr52.49 Mil) to Dec. 2022 (kr59.39 Mil) and increased from Dec. 2022 (kr59.39 Mil) to Dec. 2023 (kr64.86 Mil).

Abera Bioscience AB Additional Paid-In Capital Historical Data

The historical data trend for Abera Bioscience AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abera Bioscience AB Additional Paid-In Capital Chart

Abera Bioscience AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

14.97

52.49

59.39

64.86

Abera Bioscience AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial														59.39	59.39	64.99	64.86	68.76

Abera Bioscience AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Abera Bioscience AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Abera Bioscience AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Abera Bioscience AB (XSAT:ABERA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Svetsarvagen 15, Solna, SWE, SE-17141

Website

https://www.aberabio.com

Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.

Abera Bioscience AB (XSAT:ABERA) Headlines

No Headlines